Cow’s Milk Allergy: Prevalence, Diagnosis, and Alternative Formulations

Year : 2024 | Volume : 13 | Issue : 03 | Page : 22-26
    By

    Swati Sharma,

  • Yash Yadav,

  1. Technician, Multi-disciplinary Reteach Unit, University College of Medical Sciences & GTB Hospital, Delhi, India
  2. Senior Microbiologist, AES Laboratories, Delhi, India

Abstract

Cow’s Milk Allergy (CMA) occurs when the immune system reacts to proteins in cow’s milk, like casein and whey. In individuals with CMA, the immune system wrongly perceives these proteins as threats, causing allergic reactions when cow’s milk is consumed. Unlike lactose intolerance, which results from the body’s inability to digest lactose – a sugar in milk – due to a deficiency of the enzyme lactase, CMA is an immune system response. CMA is particularly concerning for infants and young children, as milk serves as a major nutritional source in early development. Allergic reactions can vary from mild symptoms like skin rashes and digestive problems to severe, life-threatening reactions, such as anaphylaxis [1, 2]. Understanding CMA is crucial for managing the health and nutrition of those affected, especially infants who depend on milk for their development. Worldwide, CMA affects 2–3% of infants and young children. While most children outgrow the allergy by ages 3–5, it can sometimes continue into adulthood. In adults, CMA is less common, but those affected may continue to experience allergic reactions. The prevalence of CMA can be influenced by several factors, including genetics (family history of allergies), early introduction of cow’s milk into the diet, and geographic variation (rates can differ between countries and regions). Understanding these factors helps in recognizing the populations most at risk and tailoring management strategies accordingly [3, 4].

Keywords: CMA, enzymes, lactose intolerance, infants, adults

[This article belongs to Research & Reviews : Journal of Dairy Science & Technology ]

How to cite this article:
Swati Sharma, Yash Yadav. Cow’s Milk Allergy: Prevalence, Diagnosis, and Alternative Formulations. Research & Reviews : Journal of Dairy Science & Technology. 2024; 13(03):22-26.
How to cite this URL:
Swati Sharma, Yash Yadav. Cow’s Milk Allergy: Prevalence, Diagnosis, and Alternative Formulations. Research & Reviews : Journal of Dairy Science & Technology. 2024; 13(03):22-26. Available from: https://journals.stmjournals.com/rrjodst/article=2024/view=181607



Browse Figures

References

  1. Lifschitz C, Szajewska H. Cow’s milk allergy: Evidence-based diagnosis and management for the practitioner. Eur J Pediatr. 2015;174(2):141–150. doi: 10.1007/s00431-014-2422-3.
  2. Maryniak NZ, Sancho AI, Hansen EB, Bøgh KL. Alternatives to cow’s milk-based infant formulas in the prevention and management of cow’s milk allergy. Foods. 2022;11(7):926. doi: 10.3390/foods11070926.
  3. Vandenplas Y, Brough HA, Fiocchi A, Miqdady M, Munasir Z, Salvatore S, et al. Current guidelines and future strategies for the management of cow’s milk allergy. J Asthma Allergy. 2021:1243–1256. doi: 10.2147/JAA.S276992.
  4. Vandenplas Y, Broekaert I, Domellöf M, Indrio F, Lapillonne A, Pienar C, et al. An ESPGHAN position paper on the diagnosis, management, and prevention of cow's milk allergy. J Pediatr Gastroenterol Nutr. 2024;78(2):386–413. doi: 10.1097/MPG.0000000000003897.
  5. Crittenden RG, Bennett LE. Cow’s milk allergy: A complex disorder. J Am Coll Nutr. 2005;24(6 Suppl):582S–591S. doi: 10.1080/07315724.2005.10719507.
  6. Host A, Halken S. Cow’s milk allergy: Where have we come from and where are we going?. Endocr Metab Immune Disord Drug Targets. 2014;14(1):2–8. doi: 10.2174/1871530314666140121142900.
  7. Munblit D, Perkin MR, Palmer DJ, Allen KJ, Boyle RJ. Assessment of evidence about common infant symptoms and cow’s milk allergy. JAMA pediatrics. 2020;174(6):599–608. doi: 10.1001/jamapediatrics.2020.0153.
  8. Munblit D, Perkin MR, Palmer DJ, Allen KJ, Boyle RJ. Assessment of evidence about common infant symptoms and cow’s milk allergy. JAMA pediatrics. 2020;174(6):599–608.
  9. Järvinen KM, Aro A, Juntunen‐Backman K, Suomalainen H. Large number of CD19+/CD23+ B cells and small number of CD8+ T cells as early markers for cow’s milk allergy (CMA). Pediatr Allergy Immunol. 1998;9(3):139–142. doi: 10.1111/j.1399-3038.1998.tb00360.x.
  10. Petrus NC, Schoemaker AF, van Hoek MW, Jansen L, Jansen-van der Weide MC, van Aalderen WM, et al. Remaining symptoms in half the children treated for milk allergy. Eur J Pediatr. 2015;174(6):759–765. doi: 10.1007/s00431-014-2456-6.
  11. Saarinen KM, Pelkonen AS, Mäkelä MJ, Savilahti E. Clinical course and prognosis of cow’s milk allergy are dependent on milk-specific IgE status. J Allergy Clin Immunol. 2005;116(4):869–875. doi: 10.1016/j.jaci.2005.06.018.
  12. Dupont C. Diagnosis of cow’s milk allergy in children: Determining the gold standard?. Expert Rev Clin Immunol. 2014;10(2):257–267. doi: 10.1586/1744666X.2014.874946.
  13. Fiocchi A, Bouygue GR, Albarini M, Restani P. Molecular diagnosis of cow’s milk allergy. Curr Opin Allergy Clin Immunol. 2011;11(3):216–221. doi: 10.1097/ACI.0b013e32834694ef.
  14. Hochwallner H, Schulmeister U, Swoboda I, Spitzauer S, Valenta R. Cow’s milk allergy: From allergens to new forms of diagnosis, therapy and prevention. Methods. 2014;66(1):22–33. doi: 10.1016/j.ymeth.2013.08.005.
  15. Fiocchi A, Schünemann HJ, Brozek J, Restani P, Beyer K, Troncone R, et al. Diagnosis and rationale for action against cow’s milk allergy (DRACMA): A summary report. J Allergy Clin Immunol. 2010;126(6):1119–1128. doi: 10.1016/j.jaci.2010.10.011.
  16. Vandenplas Y, Brueton M, Dupont C, Hill D, Isolauri E, Koletzko S, et al. Guidelines for the diagnosis and management of cow’s milk protein allergy in infants. Arch Dis Child. 2007;92(10):902–908. doi: 10.1136/adc.2006.110999.

 

Regular Issue Subscription Review Article
Volume 13
Issue 03
Received 21/10/2024
Accepted 25/10/2024
Published 07/11/2024
Total Visits: 161


My IP

PlumX Metrics